Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
09/14/2006 | US20060205969 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
09/14/2006 | US20060205967 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
09/14/2006 | US20060205817 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
09/14/2006 | US20060205815 Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition |
09/14/2006 | US20060204550 Food and beverages containing L-carnitine derivatives |
09/13/2006 | EP1700859A2 Method for the manufacture of anagrelide |
09/13/2006 | EP1700843A2 Method for the Manufacture of Anagrelide |
09/13/2006 | EP1700842A2 Method for the Manufacture of Anagrelide |
09/13/2006 | EP1700841A2 Method for the Manufacture of Anagrelide |
09/13/2006 | EP1700840A2 Method for the Manufacture of Anagrelide |
09/13/2006 | EP1699775A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
09/13/2006 | EP1347951B1 A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid |
09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
09/13/2006 | CN1274668C Salts of nateglinide |
09/12/2006 | CA2215069C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
09/08/2006 | WO2006092884A1 Cyclic erythritol phosphoric acid derivative and asymmetric synthesis method using the same |
09/08/2006 | WO2006051000A3 Method for preparing diastereoisomers of 4-hydroxy isoleucine |
09/08/2006 | WO2005089734A3 Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same |
09/06/2006 | EP1698611A1 Process for producing phenylacetic acid derivative |
09/06/2006 | EP1697301A2 Aminoalcohol derivatives |
09/06/2006 | EP1697300A2 Bone targeting compounds for delivering agents to the bone for interaction therewith |
09/06/2006 | EP1514112B1 Method for identifying an allosteric effector of a receptor |
09/06/2006 | CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands |
09/06/2006 | CN1827733A Organic electroluminescence device |
09/06/2006 | CN1827590A Novel pregabalin crystalline form, its preparing process and pharmaceutical compositions thereof |
09/06/2006 | CN1827587A Process for synthesizing 2-(4'-amino benzoyl) benzoic acid |
09/06/2006 | CN1273448C Method for preparing aryl alkyl hydrogen peroxide |
09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
09/05/2006 | US7101915 P-terphenyl compounds |
09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
09/05/2006 | US7101897 Farnesyl transferase inhibitors |
08/31/2006 | WO2004103074A8 Copper salts of organic acids and use thereof as fungicides |
08/31/2006 | US20060194983 Method for the manufacture of l-threonine-0-(1,1-dimethylethyl)-1,1-dimethylethyl ester |
08/31/2006 | US20060194328 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
08/31/2006 | US20060194258 Polypeptide array synthesis |
08/30/2006 | EP1694775A1 Reagent for detecting an analyte |
08/30/2006 | EP1694633A1 Di (l)-lysine monosulfate trihydrate crystal and method of making |
08/30/2006 | EP1694632A1 Process for the purification of gabapentin |
08/30/2006 | EP1694630A1 Improved method for producing chiral or enantiomer-enriched beta-amino acids, -aldehydes, -ketones and gamma-amino alcohols |
08/30/2006 | EP1282596B1 Preparation of iminodiacetic acid compounds from monoethanolamine substrates |
08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
08/30/2006 | CN1826312A Anaqueous solution of a sodium salt of HEDTA |
08/30/2006 | CN1826311A Process for the hydrogenation of aromatic compounds |
08/30/2006 | CN1826098A Production of small particles |
08/30/2006 | CN1824647A Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
08/30/2006 | CN1272320C Method for producing 4-haloalkylnicotinic acid esters |
08/30/2006 | CN1272311C Extracting method for natural amino acid mixture with rich 4-hydroxy-isolecine |
08/29/2006 | US7098365 [4-{2-[(2-hydroxy-benzylidene)-amino]-ethyl}-phenol]; plant growth regulator |
08/29/2006 | US7098362 desilylation of a silylated gabapentin; recovering the product; limits the cyclization of gabapentin to its corresponding lactam |
08/29/2006 | US7098361 Rigid ring amino acids and polyamides there from |
08/24/2006 | CA2597306A1 Compounds and uses thereof |
08/23/2006 | EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators |
08/23/2006 | EP1691847A2 Tame based chelators and uses thereof |
08/23/2006 | EP1399401B1 Solid-phase electrophilic fluorination |
08/23/2006 | EP1244646B1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same |
08/23/2006 | CN1823035A Method for reducing the formaldehyde and cyanide contents in solutions of sarcosine salts |
08/23/2006 | CN1823034A Process for producing optically active ss-hydroxy alpha aminocarboxylic acid derivative |
08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
08/23/2006 | CN1821216A Dimeglumine gadopentetate and its producing method |
08/23/2006 | CN1271167C Organic electroluminescent element |
08/23/2006 | CN1271045C Method for separating L-phenylalanine from fermentation liquor |
08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
08/22/2006 | CA2157836C L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
08/17/2006 | WO2006071995A9 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof |
08/17/2006 | WO2006054315B1 Nonaqueous liquid parenteral aceclofenac formulation |
08/16/2006 | EP1690536A2 Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders |
08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
08/16/2006 | CN1817855A Production of L-aspartase calcium |
08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
08/16/2006 | CN1817853A Method for producing phenylalanine derivative and synthetic intermediate thereof |
08/16/2006 | CN1269797C Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
08/16/2006 | CN1269793C Method for producing 3,3-diarylpropylamines |
08/15/2006 | US7091373 Comprises coupling halogenated phenylalanine compound with oranic boron compound in presence of nickel catalyst; for use as intermediates in production of medicine and agrochemicals |
08/15/2006 | US7091314 Intermediates and methods for making heptapeptide oxytocin analogues |
08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
08/10/2006 | WO2006082771A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component 1-aminocyclopropanecarboxylic acid or the like |
08/10/2006 | WO2006082166A1 Functionalized esters, amides or urethanes of perfluorinated alcohols or amines as surface modifiers |
08/10/2006 | WO2006043149A9 Novel dicarboxylic acid derivatives |
08/10/2006 | WO2005102305A3 Compositions of allosteric hemoglobin modifiers and methods of making the same |
08/10/2006 | US20060178433 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto |
08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
08/10/2006 | US20060177943 Method of inhibiting nonspecific interaction between molecules on solid phase support |
08/10/2006 | CA2595981A1 Functionalized esters, amides or urethanes of perfluorinated alcohols or amines as surface modifiers |
08/09/2006 | EP1687253A2 Diphenylamine derivatives |
08/09/2006 | EP1636163A4 Process for the preparation of gabapentin |
08/09/2006 | CN1268604C Industrial preparation method for 3-amino phenylacetic acid |
08/09/2006 | CN1268603C Process for preparing dialkylamino ethanol carboxylate and its salts |
08/08/2006 | US7087799 Such as 2,2'-methylenebis(4-methyl-6-hydroxymethylphenol) for production of photosensitive polyimides |
08/08/2006 | US7087778 synthesis of a 2-(2,3,4-trihalogenoanilino)propionic acid by treating trihaloaniline or trihalonitrobenzene with a metal catalyst and dehydrating agent; chemical intermediate for levofloxacin |
08/08/2006 | US7087732 Nucleotides and analogs having photoremovable protecting groups |
08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
08/03/2006 | WO2006080905A1 Norbornane based cycloaliphatic compounds containing methylene amine groups |
08/03/2006 | WO2006079934A2 Inhibition of sweat malodour |
08/03/2006 | US20060173188 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
08/03/2006 | US20060173067 Small molecules for the treatment of atherosclerosis |
08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
08/03/2006 | US20060173053 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
08/02/2006 | EP1685092A2 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives |